130 related articles for article (PubMed ID: 30720128)
1. SHIP1 inhibits cell growth, migration, and invasion in non‑small cell lung cancer through the PI3K/AKT pathway.
Fu Q; Huang Y; Ge C; Li Z; Tian H; Li Q; Li H; Li R; Tao X; Xue Y; Wang Y; Yang G; Fang W; Song X
Oncol Rep; 2019 Apr; 41(4):2337-2350. PubMed ID: 30720128
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
[TBL] [Abstract][Full Text] [Related]
4. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
5. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
6. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
[TBL] [Abstract][Full Text] [Related]
7. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
8. Effect of miR-21 on Apoptosis in Lung Cancer Cell Through Inhibiting the PI3K/ Akt/NF-κB Signaling Pathway in Vitro and in Vivo.
Zhou B; Wang D; Sun G; Mei F; Cui Y; Xu H
Cell Physiol Biochem; 2018; 46(3):999-1008. PubMed ID: 29669316
[TBL] [Abstract][Full Text] [Related]
9. miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1.
Zhang J; Li J; Li S; Zhou C; Qin Y; Li X
Int J Oncol; 2019 Jun; 54(6):2211-2221. PubMed ID: 30942425
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.
Yang J; Lan H; Huang X; Liu B; Tong Y
PLoS One; 2012; 7(8):e42978. PubMed ID: 22900072
[TBL] [Abstract][Full Text] [Related]
11. microRNA-877 contributes to decreased non-small cell lung cancer cell growth via the PI3K/AKT pathway by targeting tartrate resistant acid phosphatase 5 activity.
Bai X; He C; Fu B; Kong X; Bu J; Zhu K; Zheng W; Zhou F; Ni B
Cell Cycle; 2020 Dec; 19(23):3260-3276. PubMed ID: 33222607
[TBL] [Abstract][Full Text] [Related]
12. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
13. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.
Täger M; Horn S; Latuske E; Ehm P; Schaks M; Nalaskowski M; Fehse B; Fiedler W; Stocking C; Wellbrock J; Jücker M
Gene Ther; 2017 Nov; 24(11):749-753. PubMed ID: 29143813
[TBL] [Abstract][Full Text] [Related]
14. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
Tang H; Lv W; Sun W; Bi Q; Hao Y
Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
[TBL] [Abstract][Full Text] [Related]
15. MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway.
Zhao W; Sun Q; Yu Z; Mao S; Jin Y; Li J; Jiang Z; Zhang Y; Chen M; Chen P; Chen D; Xu H; Ding S; Yu Z
Gene; 2018 Sep; 670():31-37. PubMed ID: 29803922
[TBL] [Abstract][Full Text] [Related]
16. Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
Li JY; Yu J; Du XS; Zhang HM; Wang B; Guo H; Bai J; Wang JH; Liu A; Wang YL
Oncol Rep; 2016 Jul; 36(1):147-54. PubMed ID: 27177149
[TBL] [Abstract][Full Text] [Related]
17. Pectolinarigenin inhibits non‑small cell lung cancer progression by regulating the PTEN/PI3K/AKT signaling pathway.
Xu F; Gao X; Pan H
Oncol Rep; 2018 Dec; 40(6):3458-3468. PubMed ID: 30542737
[TBL] [Abstract][Full Text] [Related]
18. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
19. ESE‑1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo.
Lou Z; Lee BS; Ha T; Xu Y; Kim HJ; Kim CH; Lee SH
Oncol Rep; 2018 Sep; 40(3):1734-1742. PubMed ID: 30015943
[TBL] [Abstract][Full Text] [Related]
20. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]